(Q44850907)

6 December 2017

Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats (English)

1 reference

6 December 2017

2

1 reference

6 December 2017

4

1 reference

6 December 2017

Reuter U

1

1 reference

PubMed ID

15096229

6 December 2017

Ickenstein GW

series ordinal

3

1 reference

PubMed ID

15096229

6 December 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

6 December 2017

1 reference

6 December 2017

24

1 reference

6 December 2017

5

1 reference

6 December 2017

398-407

1 reference

Drug overuse and rebound headache

6 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Medication overuse headache: a focus on analgesics, ergot alkaloids and triptans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Acute opioid receptor desensitization and tolerance: is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

A retrospective long-term analysis of the epidemiology and features of drug-induced headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Paroxysmal headache caused by colloid cyst of the third ventricle: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Serotonin augments the cationic current Ih in central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Effect of sustained administration of the 5-HT1A receptor agonist flesinoxan on rat 5-HT neurotransmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Regulation of 5-HT(1A) receptor-stimulated [35S]-GtpgammaS binding as measured by quantitative autoradiography following chronic agonist administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Protein kinase mediated upregulation of endothelin A, endothelin B and 5-hydroxytryptamine 1B/1D receptors during organ culture in rat basilar artery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Interaction of 5-HT1B/D ligands with recombinant h 5-HT1A receptors: intrinsic activity and modulation by G-protein activation state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Coronary side-effect potential of current and prospective antimigraine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Co-localization of 5-HT(1B/1D/1F) receptors and glutamate in trigeminal ganglia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

Cranial vascular effects of zolmitriptan, a centrally active 5-HT1B/1D receptor partial agonist for the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00683.X

10.1111/J.1468-2982.2004.00683.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference

PubMed ID

15096229